You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,864,183


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,864,183 protect, and when does it expire?

Patent 10,864,183 protects EVOMELA and is included in one NDA.

This patent has twenty-two patent family members in fourteen countries.

Summary for Patent: 10,864,183
Title:Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same
Abstract: The present disclosure is directed to pharmaceutical compositions comprising a nitrogen mustard and a cyclodextrin derivative, and methods of making and using the same.
Inventor(s): Pipkin; James D. (Lawrence, KS), Machatha; Stephen G. (Overland Park, KS)
Assignee: Cydex Pharmaceuticals, Inc. (Lenexa, KS)
Application Number:16/728,840
Patent Claim Types:
see list of patent claims
Formulation;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of U.S. Patents: A Detailed Analysis

Introduction

Patents are a cornerstone of innovation, providing inventors and companies with exclusive rights to their inventions. The U.S. Patent and Trademark Office (USPTO) is the federal agency responsible for granting these patents. This article will delve into the intricacies of patent scope, claims, and the broader patent landscape, using the example of U.S. Patent 10,864,183 to illustrate key concepts.

The Role of the USPTO

The USPTO is the primary agency for handling patent and trademark applications in the United States. It grants various types of patents, including utility patents, plant patents, design patents, and trademarks[1][5].

Patent Scope and Claims

Definition of Patent Scope

Patent scope refers to the breadth and depth of protection granted by a patent. It is determined by the claims section of the patent, which outlines what the inventor considers to be their invention. The scope is crucial because it defines the boundaries of what is protected and what is not[3].

Metrics for Measuring Patent Scope

Researchers use several metrics to measure patent scope, including independent claim length and independent claim count. These metrics help in assessing the breadth of the patent and its potential impact on innovation. Narrower claims, for instance, are associated with a higher probability of grant and a shorter examination process[3].

The Claims Section

Importance of Claims

The claims section is the most critical part of a patent application. It defines the invention and sets the boundaries of what is protected. Claims can be independent or dependent, with independent claims standing alone and dependent claims referring back to an independent claim[3].

Example: U.S. Patent 10,864,183

While specific details of U.S. Patent 10,864,183 are not provided here, a typical analysis would involve examining the independent and dependent claims. For example, if the patent is for a technological innovation, the claims might detail specific components, their interactions, and the novel aspects of the invention.

Patent Examination Process

Overview

The patent examination process involves a thorough review of the patent application by USPTO examiners. This process ensures that the patent meets statutory requirements such as novelty, non-obviousness, and written description[4].

Time and Resources

The USPTO has recognized the need for adequate time and resources for examiners to conduct thorough examinations. In response, the agency has increased the time available for certain art units and engaged with stakeholders to improve the examination process[4].

Geographical Distribution of Patent Activity

County-Level Data

Patent activity can be analyzed at a county level, providing insights into regional innovation. The USPTO, in collaboration with other agencies, prepares county-level data on patents, including patent intensity, which is the number of patents issued per population[1].

Patent Quality and Correctness Measures

USPTO Initiatives

The USPTO has been working to define and improve patent quality. This includes developing correctness measures and compliance targets for statutory requirements such as 35 U.S.C. 101, 102, 112, and 103. These measures are part of the agency's effort to ensure that patents are granted with high standards of quality[4].

Case Studies: Challenges in Patent Applications

The GATT Bubble

The GATT Bubble, a period marked by a significant influx of patent applications due to changes in patent term, highlights the challenges in managing large volumes of applications. For example, Gilbert P. Hyatt filed 381 applications during this period, each with numerous claims, which posed significant challenges for the USPTO in terms of examination and review[2].

International Patent Classification

WIPO Classification

Patents are classified using the World Intellectual Property Organization's (WIPO) international patent classification (IPC) system. This system helps in categorizing patents by technology areas, allowing for more precise analysis of patent activity and trends[1].

Fractional Counts and Double Counting

To avoid double counting, especially in cases where patents have multiple inventors or owners, the USPTO uses fractional counts. This method ensures that each county or sector receives partial credit for a patent based on the number of inventors or owners associated with it[1].

Public Use Files and Data Analysis

County Patent Intensity

Public use files provided by the USPTO contain detailed data on county-level patents, including total patents, patents by technical field, and unassigned patents. These files allow for two types of analysis: one based on the location of the inventor and one based on the location of the owner[1].

Expert Insights and Statistics

Industry Experts

Industry experts emphasize the importance of clear and narrow claims to avoid litigation and licensing issues. For instance, research has shown that narrower claims are associated with higher grant rates and shorter examination times[3].

Statistics

  • In 2020, the USPTO granted over 300,000 utility patents.
  • The patent examination process tends to narrow the scope of patent claims, with longer examination durations resulting in more significant scope reductions[3].

Key Takeaways

  • Patent Scope and Claims: The scope of a patent is defined by its claims, which are critical for determining the breadth and depth of protection.
  • Examination Process: The USPTO ensures that patents meet statutory requirements through a thorough examination process.
  • Geographical Distribution: Patent activity can be analyzed at a county level to understand regional innovation trends.
  • Patent Quality: The USPTO has initiatives to define and improve patent quality, including correctness measures and compliance targets.
  • International Classification: Patents are classified using the WIPO IPC system to categorize them by technology areas.

FAQs

Q: What is the role of the USPTO in the patent process?

The USPTO is responsible for granting U.S. patents and registering trademarks. It handles patent and trademark applications and ensures that patents meet statutory requirements.

Q: How is patent scope measured?

Patent scope is measured using metrics such as independent claim length and independent claim count. These metrics help in assessing the breadth of the patent.

Q: What is the significance of the claims section in a patent application?

The claims section defines the invention and sets the boundaries of what is protected. It is the most critical part of a patent application.

Q: How does the USPTO handle large volumes of patent applications?

The USPTO has mechanisms to manage large volumes, such as increasing the time available for certain art units and hiring additional examiners, as seen during the GATT Bubble.

Q: Why is it important to avoid double counting in patent data?

Avoiding double counting ensures accurate analysis of patent activity. The USPTO uses fractional counts to assign partial credit for patents with multiple inventors or owners.

Sources

  1. Invention, Knowledge Transfer, and Innovation. NCSES, 2022.
  2. Hyatt v. Hirshfeld. Court of Appeals for the Federal Circuit, 2021.
  3. Patent Claims and Patent Scope. SSRN, 2016.
  4. Intellectual Property: Patent Office Should Define Quality, Reassess Processes. GAO, 2016.
  5. U.S. Patent and Trademark Office (USPTO). USAGov.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,864,183

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Acrotech Biopharma EVOMELA melphalan hydrochloride POWDER;INTRAVENOUS 207155-001 Mar 10, 2016 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.